1338.HK
BaWang International (Group) Holding Limited [1338.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1338.HK Stock Summary
Top 1338.HK Correlated Resources
1338.HK
Top 10 Correlated ETFs
1338.HK
Top 10 Correlated Stocks
1338.HK
1338.HK Financial details
Company Rating
Buy
Market Cap
173.93M
Income
-4.87M
Revenue
267.1M
Book val./share
0.05
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
208
Optionable
No
Shortable
Yes
Earnings
30 Aug 2022
P/E
7.27
Forward P/E
-
PEG
3.51
P/S
0.63
P/B
1.3
P/C
2.65
P/FCF
8.94
Quick Ratio
0.52
Current Ratio
1.21
Debt / Equity
0.02
LT Debt / Equity
0.29
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
124.9%
EPS next Y
-
EPS next 5Y
12536.3%
EPS last 5Y
NAN%
Revenue last 5Y
0.7%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-3%
ROC
-0.08%
Gross Margin
45%
Oper. Margin
-5%
Profit Margin
-2%
Payout
-
Shs Outstand
3.16B
Shs Float
317.29M
-
-
-
-
Target Price
-
52W Range
0.036-0.126
52W High
-
52W Low
-
RSI
63
Rel Volume
3.42
Avg Volume
245.14K
Volume
838K
Perf Week
1.92%
Perf Month
39.47%
Perf Quarter
-18.46%
Perf Half Y
-19.7%
-
-
-
-
Beta
0.656449
-
-
Volatility
0%, 0.01%
Prev Close
0%
Price
0.053
Change
8.16%
1338.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.08 | 0.09 | 0.08 | 0.09 | 0.09 | |
| Net income per share | 0.01 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0.01 | 0 | 0.01 | 0.01 | 0 | |
| Free cash flow per share | 0.01 | 0 | 0.01 | 0.01 | 0 | |
| Cash per share | 0.02 | 0.03 | 0.03 | 0.04 | 0.02 | |
| Book value per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Tangible book value per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Share holders equity per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Interest debt per share | 0 | 0 | 0.01 | 0 | 0.02 | |
| Market cap | 787.29M | 559.64M | 309.9M | 351.01M | 268.81M | |
| Enterprise value | 741.24M | 506.71M | 248.49M | 240.15M | 262.99M | |
| P/E ratio | 40.95 | -467.93 | -50.8 | -86.93 | -29.59 | |
| Price to sales ratio | 2.98 | 1.9 | 1.2 | 1.27 | 0.98 | |
| POCF ratio | 17.97 | 74.15 | 11.28 | 9.26 | 168.11 | |
| PFCF ratio | 27.27 | 106.44 | 13.33 | 10.05 | -4.14K | |
| P/B Ratio | 4.62 | 3.38 | 1.95 | 2.27 | 1.84 | |
| PTB ratio | 4.62 | 3.38 | 1.95 | 2.27 | 1.84 | |
| EV to sales | 2.81 | 1.72 | 0.96 | 0.87 | 0.96 | |
| Enterprise value over EBITDA | 20.1 | 26.72 | 16.03 | 8.92 | 10.52 | |
| EV to operating cash flow | 16.92 | 67.14 | 9.05 | 6.34 | 164.47 | |
| EV to free cash flow | 25.68 | 96.37 | 10.69 | 6.88 | -4.05K | |
| Earnings yield | 0.02 | 0 | -0.02 | -0.01 | -0.03 | |
| Free cash flow yield | 0.04 | 0.01 | 0.07 | 0.1 | 0 | |
| Debt to equity | 0 | 0 | 0.15 | 0 | 0.3 | |
| Debt to assets | 0.43 | 0.42 | 0.45 | 0.42 | 0.51 | |
| Net debt to EBITDA | -1.25 | -2.79 | -3.96 | -4.12 | -0.23 | |
| Current ratio | 1.3 | 1.43 | 1.5 | 1.6 | 1.24 | |
| Interest coverage | 28.71 | 1.75 | -8.15 | -1.54 | -4.86 | |
| Income quality | 2.28 | -6.31 | -4.5 | -9.38 | -0.18 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.11 | 0.09 | 0.12 | 0.1 | 0.11 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.34 | -0.3 | -0.15 | -0.08 | -1.04 | |
| Capex to revenue | -0.06 | -0.01 | -0.02 | -0.01 | -0.01 | |
| Capex to depreciation | -0.87 | -0.12 | -0.15 | -0.1 | -0.05 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.09 | 0.02 | 0.05 | 0.04 | 0.05 | |
| ROIC | 0.08 | 0 | -0.1 | -0.01 | -0.04 | |
| Return on tangible assets | 0.06 | 0 | -0.02 | -0.02 | -0.03 | |
| Graham Net | -0.01 | 0 | 0 | 0.01 | -0.02 | |
| Working capital | 37.84M | 50.66M | 53.73M | 65.5M | 25.02M | |
| Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
| Net current asset value | 37.84M | 50.66M | 29.93M | 65.17M | -18.29M | |
| Invested capital | 0 | 0.08 | 0.26 | 0.07 | 0.37 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 32.82M | 32.36M | 33.83M | 35.11M | 38.9M | |
| Average inventory | 37.44M | 33.46M | 28.34M | 27.31M | 34.06M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 81.39 | 69.1 | 83.03 | 76.33 | 89.27 | |
| Days of inventory on hand | 126.86 | 92.43 | 74.92 | 59.37 | 85.34 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 4.48 | 5.28 | 4.4 | 4.78 | 4.09 | |
| Inventory turnover | 2.88 | 3.95 | 4.87 | 6.15 | 4.28 | |
| ROE | 0.11 | -0.01 | -0.04 | -0.03 | -0.06 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2019-06-30 for Q2
| Metric | History | 2015-06-30 | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2019-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Net income per share | -0.01 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Book value per share | 0.02 | 0.04 | 0.05 | 0.05 | 0.05 | |
| Tangible book value per share | 0.02 | 0.04 | 0.05 | 0.05 | 0.05 | |
| Share holders equity per share | 0.02 | 0.04 | 0.05 | 0.05 | 0.05 | |
| Interest debt per share | 0.02 | 0 | 0 | 0 | 0.01 | |
| Market cap | 1.83B | 1.65B | 1.06B | 711.41M | 452.21M | |
| Enterprise value | 1.87B | 1.62B | 1.05B | 669.68M | 420.13M | |
| P/E ratio | -16.59 | 37.78 | 55.09 | -594.82 | -74.13 | |
| Price to sales ratio | 31.6 | 25 | 16.04 | 9.68 | 7.01 | |
| POCF ratio | -632.05 | -5.69K | 96.68 | 377.05 | 65.86 | |
| PFCF ratio | -525.08 | -2.74K | 146.76 | 541.2 | 77.83 | |
| P/B Ratio | 25.43 | 12.06 | 7.08 | 4.38 | 3.06 | |
| PTB ratio | 25.43 | 12.06 | 7.08 | 4.38 | 3.06 | |
| EV to sales | 32.27 | 24.51 | 15.94 | 9.11 | 6.51 | |
| Enterprise value over EBITDA | -83.67 | 118.9 | 114.21 | 141.23 | 108.41 | |
| EV to operating cash flow | -645.46 | -5.58K | 96.14 | 354.94 | 61.18 | |
| EV to free cash flow | -536.21 | -2.69K | 145.93 | 509.45 | 72.31 | |
| Earnings yield | -0.02 | 0.01 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0.01 | 0 | 0.01 | |
| Debt to equity | 0.63 | 0 | 0 | 0 | 0.02 | |
| Debt to assets | 0.75 | 0.53 | 0.48 | 0.46 | 0.43 | |
| Net debt to EBITDA | -1.74 | -2.38 | -0.65 | -8.8 | -8.28 | |
| Current ratio | 0.75 | 0.92 | 1.13 | 1.25 | 1.29 | |
| Interest coverage | -28.63 | 12.53 | 28.71 | 2.47 | -8.04 | |
| Income quality | 0.1 | -0.03 | 2.28 | -6.31 | -4.5 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.23 | 0.12 | 0.11 | 0.09 | 0.12 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.2 | 1.08 | -0.34 | -0.3 | -0.15 | |
| Capex to revenue | -0.01 | 0 | -0.06 | -0.01 | -0.02 | |
| Capex to depreciation | -0.14 | -0.1 | -0.87 | -0.12 | -0.15 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.07 | 0.06 | 0.04 | 0.01 | 0.02 | |
| ROIC | -0.23 | 0.03 | 0.02 | 0 | -0.03 | |
| Return on tangible assets | -0.09 | 0.04 | 0.02 | 0 | -0.01 | |
| Graham Net | -0.06 | -0.03 | -0.03 | -0.01 | -0.01 | |
| Working capital | -43.56M | -12.31M | 18.07M | 33.89M | 31.37M | |
| Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
| Net current asset value | -90.74M | -14.34M | 18.07M | 33.89M | 28.47M | |
| Invested capital | 0.7 | 0 | 0.06 | 0.08 | 0.14 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 39.35M | 23.46M | 34.78M | 37.62M | 34.67M | |
| Average inventory | 46.54M | 40.08M | 41.52M | 42.64M | 40.84M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 90.07 | 11.06 | 70.62 | 74.88 | 66.99 | |
| Days of inventory on hand | 130.75 | 102.88 | 111.06 | 102.32 | 102.8 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 1 | 8.14 | 1.27 | 1.2 | 1.34 | |
| Inventory turnover | 0.69 | 0.87 | 0.81 | 0.88 | 0.88 | |
| ROE | -0.38 | 0.08 | 0.03 | 0 | -0.01 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
1338.HK Frequently Asked Questions
What is BaWang International (Group) Holding Limited stock symbol ?
BaWang International (Group) Holding Limited is a CN stock , located in Guangzhou of Guangdong and trading under the symbol 1338.HK
What is BaWang International (Group) Holding Limited stock quote today ?
BaWang International (Group) Holding Limited stock price is $0.053 today.
Is BaWang International (Group) Holding Limited stock public?
Yes, BaWang International (Group) Holding Limited is a publicly traded company.
Company Profile
- Volume Average 245.14K
- Market Capitalization 173.93M
- Employee 208
- CEO Mr. Zheng He Chen
- Headquarters Guangzhou,GUANGDONG,CN
- IPO Date 2009-07-03
-
Website
https://www.bawang.com.cn 
BaWang International (Group) Holding Limited, together with its subsidiaries, designs, manufactures, trades in, and distributes Chinese herbal products in the People's Republic of China, Hong Kong, Thailand, and Malaysia. It operates through Hair-Care Products, Skin-Care Products, and Other Household and Personal Care Products segments. The company offers shampoo, hair-care, skin-care, household cleaning, and shower gel products, as well as laundry detergents and anti-bacterial hand gel under the Bawang, Royal Wind, Herborn, and Litao brands through distributors and retailers; and through online. It also manufactures, markets, and trades in household and personal care products. The company was incorporated in 2007 and is based in Guangzhou, the People's Republic of China. BaWang International (Group) Holding Limited is a subsidiary of Fortune Station Limited.
